Oruka Therapeutics senior vice president Arjun Agarwal sells $805,888 in stock
Arjun Agarwal, Senior Vice President of Finance at Oruka Therapeutics, Inc. (NASDAQ:ORKA), sold approximately 9,999 shares of the company's stock on October 12, 2026. The transaction, which amounted to $805,888, followed the exercise of employee stock options. Agarwal's sales occurred amidst a remarkable 185% return for ORKA shares over the past year, trading at $78.19.
The stock, as per InvestingPro analysis, is currently overvalued relative to its Fair Value estimate. Mr. Agarwal's shares were sold at weighted average prices between $80.0302 and $82.835 per share. These sales were executed pursuant to a Rule 10b5-1 trading plan, established on February 11, 2026. Prior to the sales, Agarwal acquired the same number of shares through employee stock options, which were exercised at prices of $12.50 and $34.39 per share.
The stock's recent performance reflects ongoing efforts to strengthen Oruka Therapeutics' management team and its treatment pipeline.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
